Free Trial

Avantor Q1 2024 Earnings Report

Avantor logo
$22.19 +0.43 (+1.98%)
As of 01:27 PM Eastern

Avantor EPS Results

Actual EPS
$0.22
Consensus EPS
$0.20
Beat/Miss
Beat by +$0.02
One Year Ago EPS
$0.29

Avantor Revenue Results

Actual Revenue
$1.68 billion
Expected Revenue
$1.68 billion
Beat/Miss
Missed by -$2.71 million
YoY Revenue Growth
-5.60%

Avantor Announcement Details

Quarter
Q1 2024
Time
Before Market Opens

Conference Call Resources

Avantor Earnings Headlines

Born out of bankruptcy, it’s produced 50% per year…
There is a wealth phenomenon that has delivered 50% returns per year, on average… And now that Trump is back in office, will likely continue to outperform every other asset by a wide margin.
Avantor price target lowered to $26 from $27 at Evercore ISI
How Is The Market Feeling About Avantor?
See More Avantor Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Avantor? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Avantor and other key companies, straight to your email.

About Avantor

Avantor (NYSE:AVTR) engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

View Avantor Profile

More Earnings Resources from MarketBeat